RVMD NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Revolution Medicines Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 187.5 USD
-0.9% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 39.4% above the Trend Line and sits at 95.6% of its 52-week range. The latest completed week returned -0.9%, after a -0.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 64/100 conviction, while the latest news-sentiment score is 60/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 3d.

Setup score 74 out of 100
Latest Close 187.5 USD 31 Jul 2026
1W Return -0.9% latest completed week
4W Return -0.9% short-term follow-through
12W Return 32.2% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 47-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.9% Latest completed week; four-week move -0.9%. Indicator stack 95/77 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.19% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 64/100 conviction; expected move 10.4%. News sentiment 60/100 60 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 39.4% above the Trend Line and sits at 95.6% of its 52-week range. The latest completed week returned -0.9%, after a -0.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9812-week average 0.86

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.9% over four weeks, 32.2% over 12 weeks, and 412.0% over one year. The current trend has remained active for 47 consecutive weeks.

Performance by holding period

1W-0.9%
4W-0.9%
12W32.2%
26W93.4%
52W412.0%
Active trend streak47 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.42Latest activity-pressure read.
Pressure change21.6%Four-week change in activity pressure.
Leadership73.58Latest relative-leadership reading.
RS change-16.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength41/100Blend of value, momentum, and quality. Underlying universe rank 60; rank 1 is best.
Value45/100Relative valuation strength. Underlying universe rank 56; rank 1 is best.
Quality44/100Profitability and accounting quality. Underlying universe rank 57; rank 1 is best.
Momentum46/100Medium-term price momentum. Underlying universe rank 55; rank 1 is best.
Growth46/100Revenue and earnings growth. Underlying universe rank 55; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-67.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.9%
Net share repurchases relative to market value.
Shareholder yield
-0.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

RVMD shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 0.06, expected move of 10.4%, and Sharemaestro trend signal active.

Conviction64/100
Expected move10.4%
Put/call volume0.06
Pressure95
Speculation40
Volatility78
Trend agreement29
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment60/100

Weighted news tone is neutral across 60 relevant articles.

25 positive · 31 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move10.4%Nearest-chain priced movement where available.
52-week drawdown-3.6%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+54.1%Week of 17 Apr.
Worst week-9.0%Week of 24 Apr.
Latest week-0.9%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains10
Flat weeks0
Modest losses8
Sharp losses2
Recent vol3.9%13-week weekly-return volatility.
Base vol11.1%52-week weekly-return volatility.
Up/down split35/17Count of positive and negative weeks in the 52-week window.
Average skew7.3% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape76/100

Trend, activity pressure, participation, and risk combine to a 76/100 tape read.

 Indicator analysis83/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.98; 8 reversal markers Next-Week ExpectancyPositive 55.19%

Next-week expectancy is positive with a 55.19% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors43/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 77 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

RVMD shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 0.06, expected move of 10.4%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 10.4% Sentiment60/100

Weighted news tone is neutral across 60 relevant articles.

Revolution Medicines (NASDAQ:RVMD) Flashes Strong Technical Breakout Setup Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.

 Research flow5 items

2 recent research articles and 3 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026187.5 USD-0.9%134.5 USD58.85 USD1.4273.589.4MOn
24 Jul 2026189.2 USD1.6%130.9 USD57.85 USD1.3880.689.3MOn
17 Jul 2026186.2 USD-0.4%127.3 USD56.80 USD1.4579.649.9MOn
10 Jul 2026186.9 USD-1.2%123.7 USD55.78 USD1.2977.399.2MOn
3 Jul 2026189.2 USD3.9%120.1 USD54.75 USD1.1787.5814.6MOn
26 Jun 2026182.1 USD11.7%116.4 USD53.71 USD1.0287.0424.9MOn
19 Jun 2026163.0 USD5.9%113.0 USD52.71 USD0.9264.2611.6MOn
12 Jun 2026153.9 USD3.1%109.9 USD51.83 USD0.9662.5912.6MOn
5 Jun 2026149.2 USD-5.2%107.0 USD51.00 USD1.0064.6017.2MOn
29 May 2026157.5 USD3.9%104.1 USD50.21 USD1.0469.2714.6MOn
22 May 2026151.6 USD4.1%100.8 USD49.36 USD0.9171.2010.3MOn
15 May 2026145.7 USD2.7%97.56 USD48.55 USD0.7270.069.2MOn
8 May 2026141.8 USD1.7%94.51 USD47.79 USD0.7068.5014.4MOn
1 May 2026139.5 USD3.1%91.39 USD47.04 USD0.2578.2118.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.